To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
When Price Dictates Treatment
When drug prices spike, health-care providers are forced to make tough choices.
Read more
 
ADVERTISEMENT
 
Abuse-Deterrent Opioids Aren’t Effective
New research suggests that the latest trend in opioids may not be so helpful.
Read more
 
ADVERTISEMENT
 
 
Recall of Not-So-Sterile Drug Products
FDA is alerting health professionals to a sterility breach with Vital Rx Inc. products.
Read more
 
Pravastatin Bottles Recalled: Actual Content Is Bupropion
International Laboratories recalling one lot of bottles labeled 40-mg pravastatin.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.